Max Healthcare Institute’s revenue in Q4FY23 rose 26% to ₹ 1,637 crores. Consolidated Profit After Tax came at ₹ 320 crores in Q4FY23 showcasing a 85% rise in profits on YoY basis. In this quarter’s results, the reports suggested that the firm has continued to deliver consistent performance in all key operational and financial indicators in Q4Y23.
Max Healthcare Inst 4Q23; 85% Growth in Profit
Tags: Healthcare
Related Post
- Natco Pharma Ltd Q2FY25; 83% rise in Profits
NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged…
-
Muthoot Finance Ltd Q2FY25; 26% rise in Profits
Muthoot Finance is NBFC engaged in the business of providing gold loans. The company predominately…
-
Multi Commodity Exchange of India Ltd Q2FY25; 73% rise in Revenue
The MCX commenced operation in Nov,03 is India’s first listed, national-level, electronic exchange, and India’s…